This episode we're joined by Dr. Joshua Lee, a clinician, researcher, and professor specializing in medication-assisted treatment (MAT) for alcohol and opioid use disorders. Dr. Lee discusses his extensive research on medications such as naltrexone and buprenorphine, their significance in treating substance use disorders, and the transformative potential of telemedicine platforms like Oar Health. He highlights the underutilization of effective medications in primary care, the barriers to accessibility, and the enduring stigma associated with addiction. The conversation also touches on emerging trends and the future of addiction treatment.Dr. Lee's BioJoshua specializes in medication-assisted treatment of alcohol and opioid use disorders. He conducts clinical trials and treats patients struggling with addiction as a primary care physician. As a Professor at NYU Grossman School of Medicine, he leads the Addiction Medicine Fellowship and conducts research focused on justice and community outcomes. https://www.oarhealth.com/https://med.nyu.edu/faculty/joshua-d-leehttps://x.com/drjoshuadlee00:00 Introduction and Podcast Overview00:38 Introducing Dr. Joshua Lee01:20 Clinical Trials and Medication Insights03:46 Challenges in Alcohol and Opioid Treatment08:50 Telemedicine and Its Impact11:59 Addressing Misconceptions and Barriers19:35 Success Rates and Future Trends30:14 Fun Personal Question Qualio website:https://www.qualio.com/ Previous episodes:https://www.qualio.com/from-lab-to-launch-podcast Apply to be on the show:https://forms.gle/uUH2YtCFxJHrVGeL8 Music by keldez

Ver todos los episodios